Financials • Life Insurance
$160.45 ▲ +2.08
(+1.31%)
MKT CAP: $12.33B • VOL: 641.8K
52W L $128 52W H $192
GL // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.99B | $5.78B | $5.45B |
| YoY Revenue Growth % | +3.7% | +6.1% | — |
| Gross Profit | $2.64B | $2.54B | $2.40B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.37B | $1.26B | $1.27B |
| Operating Margin % | 22.9% | 21.9% | 23.2% |
| Net Income (GAAP) | $1.16B | $1.07B | $970.8M |
| EBITDA (Normalized) | $1.48B | $1.32B | $1.46B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.40B | $1.40B | $1.48B |
| Capital Expenditures (CapEx) | $142.5M | $71.0M | $245.1M |
| Free Cash Flow (FCF) | $1.25B | $1.33B | $1.24B |
| FCF Margin % | 20.9% | 23.0% | 22.7% |
| Return on Invested Capital (ROIC %) | 22.1% | 22.5% | 24.4% |
| Cash & Short-Term Equivalents | $3.39B | $3.20B | $746.0M |
| Total Debt (Short + Long Term) | $2.32B | $2.32B | $1.59B |
| Total Stockholders' Equity | $5.97B | $5.31B | $3.26B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR GL.